Index of reports
> Cases with Congestive Cardiomyopathy (2)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Tasmar (Tolcapone) where reactions include congestive cardiomyopathy. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Tasmar side effects in 75 year old male
Reported by a physician from Germany on 2012-04-18
Patient: 75 year old male, weighing 79.0 kg (173.8 pounds)
Reactions: Cardiac Failure, Atrial Fibrillation, Pleural Effusion, Congestive Cardiomyopathy, Generalised Oedema
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Tasmar
Indication: Parkinson's Disease
Start date: 2010-10-07
End date: 2011-12-01
L-Dopa-Retard
Other drugs received by patient: Madopar; Clarium; L-Dopa; Azilect
Possible Tasmar side effects in 75 year old male
Reported by a physician from Germany on 2012-04-18
Patient: 75 year old male, weighing 79.0 kg (173.8 pounds)
Reactions: Cardiac Failure, Congestive Cardiomyopathy, Pleural Effusion, Atrial Fibrillation, Generalised Oedema
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Tasmar
Indication: Parkinson's Disease
Start date: 2010-10-07
End date: 2011-12-01
L-Dopa-Retard
Other drugs received by patient: Clarium; Azilect; Madopar; L-Dopa
|